SEC Comment Letter 0000000000-26-003654 to BIOLARGO, INC. (BLGO)
BIOLARGO, INC.
Date: April 10, 2026 · CIK: 0000880242 · Accession: 0000000000-26-003654
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294948
Letter
Re: BioLargo, Inc. Registration Statement on Form S-1 Filed April 09, 2026 File No. 333-294948 Dear Dennis Calvert:
April 10, 2026
Dennis Calvert Chief Executive Officer BioLargo, Inc. 14921 Chestnut St. Westminster, CA 92683
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and Services
cc: Gilbert Bradshaw, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 10, 2026 Dennis Calvert Chief Executive Officer BioLargo, Inc. 14921 Chestnut St. Westminster, CA 92683 Re: BioLargo, Inc. Registration Statement on Form S-1 Filed April 09, 2026 File No. 333-294948 Dear Dennis Calvert: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Gilbert Bradshaw, Esq. </TEXT> </DOCUMENT>